Streetbeat News

CWBHF

Charlottes Web Holdings Inc

Industry

Medicinal and Botanical Manufacturing

Open

0.09

Mkt cap

15M

Volume

91K

High

0.10

P/E Ratio

-0.41

52-wk high

0.27

Low

0.09

Div yield

N/A

52-wk low

0.07

Charlotte's Web Holdings, Inc. will release its 2024 Q4 and year-end earnings on March 19, 2025. The company is a leader in CBD hemp extract wellness products.

Portfolio Pulse from

February 25, 2025 | 6:45 pm

Charlotte's Web Holdings announced that the FDA has completed its review of Phase 1 data and IND application for DeFloria's autism treatment, allowing it to enter Phase 2 trials.

Portfolio Pulse from

February 24, 2025 | 1:15 pm

DeFloria, a collaboration between Ajna BioSciences and Charlotte's Web Holdings, has received FDA clearance for a Phase 2 clinical trial of AJA001, a cannabinoid drug for Autism Spectrum Disorder. The trial is set to begin by mid-2025.

Portfolio Pulse from

February 24, 2025 | 12:45 pm

Charlotte's Web Holdings, Inc. reported its financial results for the third quarter of 2024, highlighting sequential quarterly growth and new product innovations driving omni-channel expansion.

Portfolio Pulse from

November 14, 2024 | 12:30 pm

On November 1, 2024, several cannabis stocks experienced significant price changes. Notable gainers included Australis Capital, CordovaCann, and Cara Therapeutics, while major losers included Cann Group, Greenlane Holdings, and Canopy Growth.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:30 pm

The article reports on the performance of various cannabis stocks on October 31, 2024. Notable gainers include Australis Capital, CordovaCann, and Cara Therapeutics, while significant losers include Cann Group, Greenlane Holdings, and Canopy Growth.

Portfolio Pulse from Benzinga Insights

October 31, 2024 | 8:30 pm

The article reports on the performance of various cannabis stocks on October 30, 2024. Notable gainers include Australis Capital, CordovaCann, and Cara Therapeutics, while significant losers include Cann Group, Greenlane Holdings, and Canopy Growth.

Portfolio Pulse from Benzinga Insights

October 30, 2024 | 8:30 pm

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

On October 29, 2024, several cannabis-related stocks experienced significant price movements. Currenc Group (NASDAQ:CURR) and Encompass Health (NYSE:EHC) were among the gainers, while Eastside Distilling (NASDAQ:EAST), 22nd Century Group (NASDAQ:XXII), Cara Therapeutics (NASDAQ:CARA), Greenlane Holdings (NASDAQ:GNLN), and Urban-gro (NASDAQ:UGRO) were among the losers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 8:30 pm

Marijuana stocks experienced a bullish Monday with significant gains for several companies, including Greenlane Holdings and Global Compliance. Greenlane Holdings, listed on NASDAQ, saw a notable increase of 90.91% in its stock price.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.